0941 [Dow Jones] Shares in Australian Pharmaceutical Industries (API.AU) may rise after says 3Q sales in line with expectations. "The retail division had a positive Christmas trading period and sales for the three months are up more than 6% on the same period last year," API says. In December API forecast 1H EBITD of about A$39 million. "General trading conditions in the pharmacy industry have continued positively from January while there has been some evidence of slower growth rates in the retail sector," it says. Last trade A$1.91. (ABH)
0941 [Dow Jones] Shares in Australian Pharmaceutical Industries...
Add to My Watchlist
What is My Watchlist?